from Reuters: Health News https://reut.rs/2Gan90g
GSK pays up to $4.2 billion for Merck KGaA cancer immunotherapy
GlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agreeing to pay up to 3.7 billion euros ($4.2 billion) to Germany's Merck KGaA for the rights to a next-generation immunotherapy.
from Reuters: Health News https://reut.rs/2Gan90g
from Reuters: Health News https://reut.rs/2Gan90g
Subscribe to:
Post Comments (Atom)
-
Sometimes the best paleo snacks are frozen ones. Wether it’s because of hot weather, after a workout or just because you want to feel light ...
-
Hi everyone, not really sure what I want from this post (advice, others feeling the same, some brutal honesty etc etc) but I just need to g...
-
I’m not even exaggerating when I say that these are literally the best Belgian waffles that I’ve ever tasted. My previous Belgian waffle i...
No comments:
Post a Comment